BioBridgeXAll companies

Autolus Therapeutics plc

Biotechnology company · London, England, United Kingdom · Nasdaq: AUTL

Autolus Therapeutics plc is a biotechnology company headquartered in London, England, United Kingdom. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker AUTL. It is registered with UK Companies House under company number 11185179.

Profile compiled from public records. Is this your company? Request a correction or update

Autolus Therapeutics at a glance

Typebiotechnology company
HeadquartersLondon, England, United Kingdom
Earliest incorporation on record2018
Stock listingNasdaq: AUTL
SEC industryBiological Products, (No Diagnostic Substances)
Registered activities (UK)Activities of other holding companies n.e.c.; Research and experimental development on biotechnology
UK company number11185179
SEC CIK1730463

Frequently asked questions about Autolus Therapeutics

Where is Autolus Therapeutics headquartered?

Autolus Therapeutics plc is headquartered in London, England, United Kingdom.

What does Autolus Therapeutics do?

Autolus Therapeutics plc is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Autolus Therapeutics a public company?

Yes. Autolus Therapeutics plc trades on Nasdaq under the ticker AUTL.

When was Autolus Therapeutics founded?

The earliest incorporation on record for Autolus Therapeutics plc is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences